Depleting B cells through anti-CD20 antibody treatment or blocking co-stimulatory signals mediated by CD86 through CTLA-4-Ig diminished intestinal inflammation in a mouse model of chronic inflammatory-bowel disease at the onset of disease.
[Mucosal Immunology]